UBS Group’s Leverage Shares 2X Long CRCL Daily ETF CRCG Stock Holding History

UBS Group’s Portfolio CRCG Stock Details CRCG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.68M	Buy	310,850 +309,060	+17,266%	+$7.9M	﹤0.01%	4826
2026 Q1	$48.7K	Buy	1,790 +1,531	+591%	+$41.4K	﹤0.01%	7384
2025 Q4	$6.74K	Buy	+259	New	+$14.2K	﹤0.01%	8517

Other funds holding CRCG

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

GFG

Genesis Financial Group Paramus, New Jersey $154M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

UBS Group's CRCG Position: Q2 2026 in Review

UBS Group increased its Leverage Shares 2X Long CRCL Daily ETF (CRCG) stake by 17,266% in Q2 2026, buying an estimated $7.9M and bringing the position to 310,850 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #4826.

UBS Group first reported a position in CRCG in Q4 2025 and has held it in 3 quarters since. 8 funds tracked by Wall St. Rank hold CRCG as of Q2 2026.

UBS Group held 310,850 shares of Leverage Shares 2X Long CRCL Daily ETF worth $2.68M as of Q2 2026.
UBS Group bought 309,060 Leverage Shares 2X Long CRCL Daily ETF shares in Q2 2026, an estimated $7.9M.
Leverage Shares 2X Long CRCL Daily ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4826 holding.
UBS Group first reported a position in Leverage Shares 2X Long CRCL Daily ETF in Q4 2025 and has held it in 3 quarters since.
8 funds tracked by Wall St. Rank held Leverage Shares 2X Long CRCL Daily ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.